Non-alcoholic fatty liver disease (NAFLD). Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: Group receiving diet and physical activity. Intervention 2: Control group: Group without diet and physical activity.
Sponsors
Iran Health Insurance Organization
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patients with non-alcoholic fatty liverdisease
Exclusion criteria
Exclusion criteria: Cardiovascular, thyroid, renal, inflammatory, autoimmune, hepatitis B and C, hereditary hemochromatosis, Wilson Alcohol consumers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Aspartate trans amylase. Timepoint: At the beginning of the study and 12 weeks after the intervention. Method of measurement: Spectrophotometric method.;Alanine amino transferase. Timepoint: At the beginning of the study and 12 weeks after the intervention. Method of measurement: Spectrophotometric method.;Body Mass index. Timepoint: At the beginning of the study and 12 weeks after the intervention. Method of measurement: Divide weight by height squared. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactleila javadi
Health Insurance Organization
Outcome results
None listed